Negative Pressure Wound Therapy Market

Negative Pressure Wound Therapy Market Summary

The global negative pressure wound therapy market size was estimated at USD 2.79 billion in 2025 and is projected to reach USD 4.54 billion by 2033, growing at a CAGR of 6.29% from 2026 to 2033. The market is primarily driven by the rising incidence of chronic wounds and surgical procedures, particularly among aging populations and patients with diabetes or obesity.

The growing clinical preference for advanced wound care solutions that accelerate healing, reduce infection risk, and shorten hospital stays is further supporting their adoption. In addition, technological advancements, such as portable and disposable NPWT systems, are expanding use beyond hospitals into home-care settings. Increasing healthcare expenditure and greater awareness of evidence-based wound management are also contributing to sustained market growth.

The rising incidence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is a key driver of the negative pressure wound therapy industry. The increasing diabetes prevalence and an aging population lead to more complex, slow-healing wounds that often respond poorly to conventional care. NPWT offers improved healing outcomes and lower complication risks, encouraging greater adoption by healthcare providers and driving sustained demand for NPWT devices and dressings.

The rising number of hospital admissions is a key driving factor in the negative pressure wound therapy industry, as it expands the number of patients requiring advanced wound management for surgical incisions, trauma, pressure ulcers, and chronic wounds. Higher admission rates lead to greater volumes of complex procedures and post-operative care, where NPWT is commonly used to reduce complications and speed healing. As hospitals prioritize shorter length of stay and better outcomes, NPWT adoption increases as a standard component of inpatient wound care.

The increasing volume of surgical procedures and traumatic injuries is another factor driving growth in the negative pressure wound therapy industry, as such wounds often require advanced management to prevent complications. NPWT promotes faster healing, lowers infection risk, and improves post-operative outcomes, making it a preferred solution across surgical and trauma care settings.

According to the World Population Review, in 2024, the number of surgical procedures was approximately 2.0 million, while non-surgical procedures accounted for about 4.2 million cases.

The growing clinical evidence highlighting the effectiveness of negative pressure wound therapy is a key driver of market growth. Numerous trials and real-world studies have demonstrated that NPWT promotes faster wound closure, improves granulation tissue formation, and reduces infection risk compared with traditional dressings. This strong clinical validation has increased clinician confidence, leading to broader adoption across hospitals, outpatient centers, and home care settings, and supporting its inclusion in standard wound care protocols.

The expansion of wound care manufacturing facilities is correlated with the growing evidence supporting the efficacy of NPWT. For instance, in September 2025, Mölnlycke Health Care, a global MedTech provider headquartered in Gothenburg, Sweden, announced the groundbreaking of a major expansion of its wound care manufacturing facility in Brunswick, Maine, U.S. This milestone marks the beginning of a USD135 million investment aimed at substantially expanding Mölnlycke’s manufacturing capacity in the U.S.

“This expansion is a bold step forward for Mölnlycke in the U.S. It reinforces our mission to free patients and caregivers from the burden of wounds, strengthens supply resilience, and helps us to deliver high-quality wound care solutions faster, smarter, and more sustainably,” says Zlatko Rihter, CEO of Mölnlycke. “I’m proud to mark this milestone for Mölnlycke, for Maine, and for the future of MedTech.”

“Today isn’t just about breaking ground. It’s about being bold, embracing partnerships and leading with passion,” says Chris Biddle, General Manager of U.S. Manufacturing, Wound Care. “Thank you to everyone who helped bring this vision to reality. The expansion is a win for Mölnlycke, for the local community and, ultimately, for the patients we serve.”

Global Negative Pressure Wound Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global negative pressure wound therapy market report based on the product, wound type, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Conventional NPWT Devices
• Portable/Disposable NPWT
• Disposable Portable NPWT
• Reusable Portable NPWT
• NPWT Accessories
• Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Wound
• Surgical & Traumatic Wounds
• Burns
• Chronic Wound
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Other Chronic Wounds
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Home Healthcare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Sweden
• Denmark
• Norway
• Germany
• UK
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more